MedPath

ENLARGEMENT OF MALE BREAST: OUTCOME OF MEDICAL AND SURGICAL MANAGEMENT

Not Applicable
Registration Number
CTRI/2015/01/005440
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients coming to surgical/ endocrinology OPD with the diagnosis of gynecomastia.

Exclusion Criteria

1. Patients who are unwilling or unable to provide informed consent.

2. Patients who have contraindications to tamoxifen therapy viz history of thromboembolism, stroke, and coronary artery disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cosmesis scoreTimepoint: 6 months from surgery
Secondary Outcome Measures
NameTimeMethod
Surgical complicationsTimepoint: Withing 6 months of surgery
© Copyright 2025. All Rights Reserved by MedPath